Published in Ann Rheum Dis on October 01, 2002
Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s. Ann Rheum Dis (2005) 2.11
The influence of age at symptom onset and length of followup on mortality in patients with recent-onset inflammatory polyarthritis. Arthritis Rheum (2008) 1.04
Rheumatoid arthritis--early diagnosis and disease management. Dtsch Arztebl Int (2013) 1.02
Early functional disability predicts both all-cause and cardiovascular mortality in people with inflammatory polyarthritis: results from the Norfolk Arthritis Register. Ann Rheum Dis (2006) 1.01
Mortality of rheumatoid arthritis in Japan: a longitudinal cohort study. Ann Rheum Dis (2005) 0.94
Predicting factors for severity of rheumatoid arthritis: a prospective multicenter cohort study of 172 patients over 3 years. Rheumatol Int (2007) 0.83
Targeting cardiovascular risk in rheumatoid arthritis: a dual role for statins. Nat Rev Rheumatol (2010) 0.81
Endothelial progenitor cell levels in juvenile idiopathic arthritis patients: effects of anti-inflammatory therapies. Pediatr Rheumatol Online J (2015) 0.79
Effects of acute exercise on circulating endothelial and progenitor cells in children and adolescents with juvenile idiopathic arthritis and healthy controls: a pilot study. Pediatr Rheumatol Online J (2015) 0.79
Cardiovascular disease risk scores in the current practice: which to use in rheumatoid arthritis? J Med Life (2015) 0.76
Vascular disease as a cause of death in patients with severe disability due to osteoarthritis and rheumatoid arthritis. Springerplus (2015) 0.75
[Novel approach for the early detection of inflammatory rheumatic diseases in the population using a mobile screening unit]. Z Rheumatol (2010) 0.75
Improvement in 5-year mortality in incident rheumatoid arthritis compared with the general population-closing the mortality gap. Ann Rheum Dis (2016) 0.75
[Early diagnosis of rheumatoid arthritis]. Z Rheumatol (2005) 0.75
[Gold as an alternative in the treatment of RA patients with malignancies]. Z Rheumatol (2016) 0.75
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum (1988) 111.05
Measurement of patient outcome in arthritis. Arthritis Rheum (1980) 21.31
Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn (Stockh) (1977) 9.55
The mortality of rheumatoid arthritis. Arthritis Rheum (1994) 6.18
Smoking and risk of rheumatoid arthritis. J Rheumatol (1993) 3.63
The epidemiology of rheumatoid arthritis in Rochester, Minnesota: a study of incidence, prevalence, and mortality. Am J Epidemiol (1980) 3.19
Survival, prognosis, and causes of death in rheumatoid arthritis. Arthritis Rheum (1986) 2.55
Extra-articular rheumatoid arthritis: prevalence and mortality. Rheumatology (Oxford) (1999) 2.53
Response to methotrexate treatment is associated with reduced mortality in patients with severe rheumatoid arthritis. Arthritis Rheum (2000) 2.29
Mortality in rheumatoid arthritis patients with disease onset in the 1980s. Ann Rheum Dis (1999) 2.12
Cause of death in rheumatoid arthritis. Br J Rheumatol (1984) 2.12
Ten year mortality and causes of death in patients with rheumatoid arthritis. Br Med J (Clin Res Ed) (1985) 2.10
Mortality in rheumatoid arthritis: have we made an impact in 4 decades? J Rheumatol (1999) 2.07
Longterm mortality outcome in patients with rheumatoid arthritis: early presenters continue to do well. J Rheumatol (1998) 2.00
Survival and cause of death in rheumatoid arthritis: a 25-year prospective followup. J Rheumatol (1984) 1.75
Prediction of long-term mortality in patients with rheumatoid arthritis according to simple questionnaire and joint count measures. Ann Intern Med (1994) 1.74
Increased mortality among persons with rheumatoid arthritis, but where RA does not appear on death certificate. Eleven-year follow-up of an epidemiological study. Scand J Rheumatol (1981) 1.72
Increased mortality in rheumatoid arthritis. Scand J Rheumatol (1982) 1.67
Death attributed to antirheumatic medication in a nationwide series of 1666 patients with rheumatoid arthritis who have died. J Rheumatol (1995) 1.66
Amyloidosis in a nationwide series of 1666 subjects with rheumatoid arthritis who died during 1989 in Finland. Rheumatology (Oxford) (1999) 1.53
Rheumatoid arthritis and mortality. A longitudinal study in Pima Indians. Arthritis Rheum (1993) 1.52
No increased mortality in patients with rheumatoid arthritis: up to 10 years of follow up from disease onset. Ann Rheum Dis (2000) 1.40
Mortality predictors among 263 patients with rheumatoid arthritis. J Rheumatol (1991) 1.35
Factors predicting death, survival and functional outcome in a prospective study of early rheumatoid disease over fifteen years. Br J Rheumatol (1993) 1.34
Corticosteroids: do they damage the cardiovascular system? Postgrad Med J (1994) 1.32
Factors predicting a poor life prognosis in rheumatoid arthritis: an eight year prospective study. Ann Rheum Dis (1989) 1.31
Mortality in rheumatoid arthritis. Semin Arthritis Rheum (1995) 1.26
Mortality in a cohort of Norwegian patients with rheumatoid arthritis followed from 1977 to 1992. Scand J Rheumatol (2000) 1.24
Mortality and survival in rheumatoid arthritis: a 25 year prospective study of 100 patients. Ann Rheum Dis (1990) 1.21
Total mortality is increased in rheumatoid arthritis. A 17-year prospective study. Clin Rheumatol (2001) 1.17
Shortening of life span and causes of excess mortality in a population-based series of subjects with rheumatoid arthritis. Clin Exp Rheumatol (1995) 1.13
Does exposure to immunosuppressive therapy increase the 10 year malignancy and mortality risks in rheumatoid arthritis? A matched cohort study. Br J Rheumatol (1996) 1.12
The natural history of rheumatoid arthritis. J Rheumatol Suppl (1996) 1.12
Death rate and causes of death in RA patients during a period of five years. Scand J Rheumatol (1977) 1.09
Reevaluating the therapeutic approach to rheumatoid arthritis: the "sawtooth" strategy. J Rheumatol Suppl (1990) 1.08
Methotrexate effects in patients with rheumatoid arthritis with cardiovascular comorbidity. Lancet (2000) 1.01
Mortality from rheumatoid arthritis in France, 1970-1990. Int J Epidemiol (1994) 1.00
Long-term outcome of rheumatoid arthritis. Scand J Rheumatol Suppl (1992) 1.00
Death certificate and mortality in rheumatoid arthritis. Scand J Rheumatol (1986) 0.98
Mortality in early "sawtooth" treated rheumatoid arthritis patients during the first 8-14 years. Scand J Rheumatol (1999) 0.94
Mortality in rheumatoid arthritics. Br J Prev Soc Med (1972) 0.87
Functional status predicts mortality in a community based rheumatoid arthritis population. J Rheumatol (1998) 0.87
Cancer mortality in patients with rheumatoid arthritis. J Rheumatol (1986) 0.80
Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group. Lancet (1999) 4.98
2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis (2011) 4.78
ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis (2005) 4.31
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis (2009) 3.32
Disparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST-RA database. Ann Rheum Dis (2009) 2.61
Is DAS28 an appropriate tool to assess remission in rheumatoid arthritis? Ann Rheum Dis (2005) 2.58
Increased incidence of alcohol-related deaths from accidents and violence in subjects with ankylosing spondylitis. Br J Rheumatol (1998) 2.28
New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS). Ann Rheum Dis (2009) 2.22
Sulfasalazine in the treatment of spondylarthropathy. A randomized, multicenter, double-blind, placebo-controlled study. Arthritis Rheum (1995) 2.16
Double-blind, placebo-controlled study of three-month treatment with lymecycline in reactive arthritis, with special reference to Chlamydia arthritis. Arthritis Rheum (1991) 2.10
Only high disease activity and positive rheumatoid factor indicate poor prognosis in patients with early rheumatoid arthritis treated with "sawtooth" strategy. Ann Rheum Dis (1998) 2.09
Non-specific musculoskeletal pain in preadolescents. Prevalence and 1-year persistence. Pain (1997) 2.04
Cardiovascular diseases in patients with rheumatoid arthritis. Scand J Rheumatol (2012) 2.03
Cardiovascular mortality in women with rheumatoid arthritis. J Rheumatol (1995) 1.96
Antikeratin antibodies: diagnostic and prognostic markers for early rheumatoid arthritis. Ann Rheum Dis (1992) 1.86
Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis. Ann Rheum Dis (2004) 1.76
Joint hypermobility is not a contributing factor to musculoskeletal pain in pre-adolescents. J Rheumatol (1996) 1.67
Prevalence and incidence of dermatitis herpetiformis: a 40-year prospective study from Finland. Br J Dermatol (2011) 1.62
Three month treatment of reactive arthritis with azithromycin: a EULAR double blind, placebo controlled study. Ann Rheum Dis (2004) 1.58
Uveitis in young adults with juvenile idiopathic arthritis: a clinical evaluation of 123 patients. Ann Rheum Dis (2005) 1.54
Amyloidosis in a nationwide series of 1666 subjects with rheumatoid arthritis who died during 1989 in Finland. Rheumatology (Oxford) (1999) 1.53
Increased level of YKL-40 in sera from patients with early rheumatoid arthritis: a new marker for disease activity. Rheumatol Int (2001) 1.53
Sonographic analysis of enthesopathy in the lower extremities of patients with spondylarthropathy. Clin Exp Rheumatol (1994) 1.52
Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components. Ann Rheum Dis (1999) 1.44
Muscle strength characteristics and central bone mineral density in women with recent onset rheumatoid arthritis compared with healthy controls. Scand J Rheumatol (1999) 1.44
Granulocyte colony-stimulating factor therapy and systemic inflammation in critically ill patients. Inflamm Res (2005) 1.43
Work disability in an inception cohort of patients with seropositive rheumatoid arthritis: a 20 year study. Rheumatology (Oxford) (1999) 1.43
Juvenile chronic arthritis in adult life: a study of long-term outcome in patients with juvenile chronic arthritis or adult rheumatoid arthritis. Clin Rheumatol (1999) 1.43
Prognosis and mortality of polymyositis and dermatomyositis patients. Clin Rheumatol (2006) 1.43
Psychiatric and cardiovascular comorbidities as causes of long-term work disability among individuals with recent-onset rheumatoid arthritis. Scand J Rheumatol (2014) 1.42
Threefold increased risk of hip fractures with rheumatoid arthritis in Central Finland. Ann Rheum Dis (2001) 1.41
Reduced mortality in dermatitis herpetiformis: a population-based study of 476 patients. Br J Dermatol (2012) 1.40
Turnip rape and oilseed rape are new potential food allergens in children with atopic dermatitis. Allergy (2006) 1.39
Campylobacter-triggered reactive arthritis: a population-based study. Rheumatology (Oxford) (2002) 1.38
Incidence of second hip fractures. A population-based study. Osteoporos Int (2007) 1.35
Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus. Lancet (1993) 1.34
Adolescent flexibility, endurance strength, and physical activity as predictors of adult tension neck, low back pain, and knee injury: a 25 year follow up study. Br J Sports Med (2006) 1.32
Annual incidence of inflammatory joint diseases in a population based study in southern Sweden. Ann Rheum Dis (2002) 1.32
Long term safety of methotrexate in routine clinical care: discontinuation is unusual and rarely the result of laboratory abnormalities. Ann Rheum Dis (2004) 1.31
Work disability in rheumatoid arthritis 10 years after the diagnosis. J Rheumatol (1999) 1.29
Occurrence of uveitis in recently diagnosed juvenile chronic arthritis: a prospective study. Ophthalmology (2001) 1.28
Continuous progression of radiological destruction in seropositive rheumatoid arthritis. J Rheumatol (1997) 1.21
Antibodies against cyclic citrullinated peptide (CCP) and levels of cartilage oligomeric matrix protein (COMP) in very early arthritis: relation to diagnosis and disease activity. Scand J Rheumatol (2004) 1.21
The European ankylosing spondylitis infliximab cohort (EASIC): a European multicentre study of long term outcomes in patients with ankylosing spondylitis treated with infliximab. Clin Exp Rheumatol (2011) 1.19
Reactive arthritis following an outbreak of Salmonella infection in Finland. Br J Rheumatol (1994) 1.19
Finnish case-control and family studies support PTPN22 R620W polymorphism as a risk factor in rheumatoid arthritis, but suggest only minimal or no effect in juvenile idiopathic arthritis. Genes Immun (2005) 1.19
Reactive arthritis. Clin Rheum Dis (1985) 1.18
Sulfasalazine in the treatment of ankylosing spondylitis. A twenty-six-week, placebo-controlled clinical trial. Arthritis Rheum (1988) 1.18
Outcome in patients with early rheumatoid arthritis treated according to the "sawtooth" strategy. Arthritis Rheum (1996) 1.17
Clinical, radiographic and MRI findings of the temporomandibular joint in patients with different rheumatic diseases. Int J Oral Maxillofac Surg (2006) 1.17
Production of tumour necrosis factor and interleukin 1 by monocytes of patients with previous Yersinia arthritis. Clin Exp Immunol (1988) 1.16
Periarticular corticosteroid treatment of the sacroiliac joint in patients with seronegative spondylarthropathy. Clin Exp Rheumatol (1999) 1.15
Shortening of life span and causes of excess mortality in a population-based series of subjects with rheumatoid arthritis. Clin Exp Rheumatol (1995) 1.13
Circulating immune complexes containing chlamydial lipopolysaccharide in acute myocardial infarction. Microb Pathog (1990) 1.13
Comparison of narrowband ultraviolet B exposure and oral vitamin D substitution on serum 25-hydroxyvitamin D concentration. Br J Dermatol (2012) 1.12
Antifilaggrin antibodies in recent-onset arthritis. Scand J Rheumatol (1999) 1.11
Combination drug therapy retards the development of rheumatoid atlantoaxial subluxations. Arthritis Rheum (2000) 1.09
Favourable social functioning and health related quality of life of patients with JIA in early adulthood. Ann Rheum Dis (2005) 1.09
Effectiveness of adalimumab in treating patients with active psoriatic arthritis and predictors of good clinical responses for arthritis, skin and nail lesions. Ann Rheum Dis (2009) 1.09
Can we rely on magnetic resonance imaging when evaluating unstable atlantoaxial subluxation? Ann Rheum Dis (2003) 1.08
Chlamydia pneumoniae as a triggering infection in reactive arthritis. Rheumatology (Oxford) (1999) 1.08
Progression of cervical spine changes in patients with early rheumatoid arthritis. J Rheumatol (1997) 1.08
Neutrophil CD11b expression and circulating interleukin-8 as diagnostic markers for early-onset neonatal sepsis. Pediatrics (2001) 1.08
Reactive arthritis attributable to Shigella infection: a clinical and epidemiological nationwide study. Ann Rheum Dis (2004) 1.07
[Rheumatoid arthritis shortens life]. Duodecim (1995) 1.07
Association of autoantibodies to filaggrin with an active disease in early rheumatoid arthritis. Ann Rheum Dis (2001) 1.07
Occurrence of different ensuing triggering infections preceding reactive arthritis: a follow up study. Br Med J (Clin Res Ed) (1988) 1.06
Prevalence of spinal cord injury in Helsinki. Spinal Cord (2005) 1.06
[Antibiotic treatment in rheumatoid arthritis?]. Duodecim (1995) 1.06
Cell-mediated immune response in the diseased joints in patients with reactive arthritis. Scand J Immunol (1986) 1.06
Narrowband ultraviolet B treatment improves vitamin D balance and alters antimicrobial peptide expression in skin lesions of psoriasis and atopic dermatitis. Br J Dermatol (2010) 1.06
Pain and joint mobility explain individual subdimensions of the health assessment questionnaire (HAQ) disability index in patients with rheumatoid arthritis. Ann Rheum Dis (2004) 1.06
Gender differences in C-reactive protein, interleukin-1 receptor antagonist and adiponectin levels in the metabolic syndrome: a population-based study. Diabet Med (2008) 1.05
Incidence of traumatic spinal cord injuries in Finland over a 30-year period. Spinal Cord (2008) 1.04
Serum hyaluronate level as a predictor of radiologic progression in early rheumatoid arthritis. Arthritis Rheum (1991) 1.02
Correlation between mobility restrictions and radiologic changes in ankylosing spondylitis. Spine (Phila Pa 1976) (1995) 1.02
Quality of life and physical performance and activity of breast cancer patients after adjuvant treatments. Psychooncology (2010) 1.02
Clinical assessment of spinal mobility measurements in ankylosing spondylitis: a compact set for follow-up and trials? Clin Rheumatol (2000) 1.02
Rise in serum C reactive protein after hip and knee arthroplasties in patients with rheumatoid arthritis. Ann Rheum Dis (2001) 1.01
Cow's milk allergy: diagnostic accuracy of skin prick and patch tests and specific IgE. Allergy (1999) 1.00
Salmonella-specific antibodies in reactive arthritis. J Infect Dis (1991) 0.99
Contributing factors to the persistence of musculoskeletal pain in preadolescents: a prospective 1-year follow-up study. Pain (1998) 0.98
Type I collagen degradation product in serum of patients with early rheumatoid arthritis: relationship to disease activity and radiological progression in a 3-year follow-up. Br J Rheumatol (1994) 0.98
Treatment strategy, disease activity, and outcome in four cohorts of patients with early rheumatoid arthritis. Ann Rheum Dis (2001) 0.98
Sustained efficacy and safety, including patient-reported outcomes, with etanercept treatment over 5 years in patients with ankylosing spondylitis. Clin Exp Rheumatol (2010) 0.98